PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Neurochemistry International

2 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Neurochemistry International has 2 tracked papers indexed in Blossom (2021–2022) from 7 authors, most often covering Ketamine and MDMA, across Veterans, PTSD and Substance Use Disorders (SUD).

Published Papers

Open Accessmeta

MDMA related neuro-inflammation and adenosine receptors

This review (2022) explores the cellular mechanisms involved in MDMA neuroinflammatory effects. The protective effects of adenosine receptors is also discussed.

Published
January 3, 2022
Journal
Neurochemistry International
Authors
Kermanian, F., Seghatoleslam, M., Mahakizadeh, S.
Paywallmeta

Ketamine For Post-Traumatic Stress Disorders And Its Possible Therapeutic Mechanism

This review (2021) investigates the possibility of ketamine being used to treat Post-Traumatic Stress Disorder (PTSD).

Published
April 13, 2021
Journal
Neurochemistry International
Authors
Asim, M., Wang, B., Hao, B., Wang, X.

Quick Facts

Papers Indexed
2
h-Index
141
Open Access
No
Publisher
Elsevier
Country
United Kingdom
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.